Unknown

Dataset Information

0

Therapeutic Approaches to RAS Mutation.

ABSTRACT: The study of oncogenic RAS mutations has led to crucial discoveries regarding cancer molecular biology and behavior and has been integral in shaping the era of targeted cancer therapy. RAS mutations are one of the most common oncogenic drivers in human cancer, and intense efforts to find a clinically effective inhibitor are ongoing. Despite these efforts, targeting RAS mutations has remained elusive, so much so that some have termed oncogenic RAS mutations as "undruggable." In this review, we will summarize current understanding of RAS biology, explore strategies to inhibit RAS oncoproteins and its downstream effectors, and discuss recently described complexities that have shed new light on this pursuit.

SUBMITTER: Scott AJ 

PROVIDER: S-EPMC4959441 | biostudies-literature | 2016 May-Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Therapeutic Approaches to RAS Mutation.

Scott Aaron J AJ   Lieu Christopher H CH   Messersmith Wells A WA  

Cancer journal (Sudbury, Mass.) 20160501 3

The study of oncogenic RAS mutations has led to crucial discoveries regarding cancer molecular biology and behavior and has been integral in shaping the era of targeted cancer therapy. RAS mutations are one of the most common oncogenic drivers in human cancer, and intense efforts to find a clinically effective inhibitor are ongoing. Despite these efforts, targeting RAS mutations has remained elusive, so much so that some have termed oncogenic RAS mutations as "undruggable." In this review, we wi  ...[more]

Similar Datasets

Unknown Approaches to inhibiting oncogenic K-Ras.
| S-EPMC7849769 | biostudies-literature
Unknown Toxin-based therapeutic approaches.
| S-EPMC3153180 | biostudies-literature
Transcriptomics Arthritis pathogenesis: Development of novel diagnostic and therapeutic approaches
2011-02-17 | E-GEOD-27358 | biostudies-arrayexpress
Unknown Current Approaches in NSCLC Targeting K-RAS and EGFR.
| S-EPMC6888213 | biostudies-literature
Unknown Developing therapeutic approaches for metachromatic leukodystrophy.
| S-EPMC3743609 | biostudies-other
Unknown New Therapeutic Approaches in Diabetic Retinopathy.
| S-EPMC5397990 | biostudies-other
Genomics Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer
2016-10-25 | E-GEOD-78286 | biostudies-arrayexpress
Unknown Biology, pathology, and therapeutic targeting of RAS.
| S-EPMC7393484 | biostudies-literature
Unknown Glioblastoma multiforme: novel therapeutic approaches.
| S-EPMC3302066 | biostudies-literature
Unknown Therapeutic approaches for cardiac regeneration and repair.
| S-EPMC6241533 | biostudies-other